An update on the biology of sphingosine 1-phosphate receptors
Open accessThe DOI matches its Crossref record; 180 of the 184 references it cites were found in a registry or an index.
Abstract
Sphingosine 1-phosphate (S1P) is a membrane-derived lysophospholipid that acts primarily as an ex-tracellular signaling molecule. Signals initiated by S1P are transduced by five G protein-coupled receptors, named S1P1-5 Cellular and temporal expression of the S1P receptors (S1PRs) determine their specific roles in various organ systems, but they are particularly critical for regulation of the cardiovascular, immune, and nervous systems, with the most well-known contributions of S1PR signaling being modulation of vascular barrier function, vascular tone, and regulation of lymphocyte trafficking. However, our knowledge of S1PR biology is rapidly increasing as they become attractive therapeutic targets in several diseases, such as chronic inflammatory pathologies, autoimmunity, and cancer. Understanding how the S1PRs regulate interactions between biological systems will allow for greater efficacy in this novel therapeutic strategy as well as characterization of complex physiological networks. Because of the rapidly expanding body of research, this review will focus on the most recent advances in S1PRs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas DCs express S1PR1, S1PR3 and S1PR4, T cells display S1PR1 and S1PR4 (refs164–166)”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [166]
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Cited by
Items 201–300 of 548
Imeri, F., Schwalm, S. A., Lyck, R., Živković, A., Stark, H., Engelhardt, B., Pfeilschifter, J. M., & Huwiler, A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.031 · Cited by 25
Tsai, H., Huang, Y., Garris, C., Moreno, M. A., Griffin, C., & Han, M. H. (2016) · JCI Insight · doi:10.1172/jci.insight.86462 · Cited by 25
“Existing studies suggest that S1PR1 and S1PR4 are predominantly expressed in CD4+ T cells (32).”
BackgroundGiguère, F. S.-C., Essis, S. A., Chagniel, L., Germain, M., Cyr, M., & Massicotte, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.014 · Cited by 26
Yu, F., Yuan, C., Tong, J., Zhang, G.-H., Zhou, F., & Yang, F. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.106 · Cited by 24
Lipid phosphate phosphatase-2 promotes tumor growth through increased c-Myc expression
Tang, X., Cromwell, C. R., Liu, R., Godbout, R., Hubbard, B. P., McMullen, T. P. W., & Brindley, D. N. (2022) · Theranostics · doi:10.7150/thno.66230 · Cited by 23
“The ecto-activity of LPP1 and LPP3 against LPA has been shown to be critical for the anti-tumor effects [10], since LPA is a potent mediators of tumor growth, metastasis and inflammation [5-7].”
BackgroundArish, M., Alaidarous, M., Ali, R. A., Akhter, Y., & Rub, A. (2017) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2017.1358282 · Cited by 24
“This bioactive mediator acts through binding to extracellular GPCRs that are involved in multiple downstream signaling pathways [11].”
BackgroundTargeting Sphingosine-1-Phosphate Signaling in Breast Cancer
Nagahashi, M., & Miyoshi, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063354 · Cited by 23
Kusumi, K., Shinozaki, K., Yamaura, Y., Hashimoto, A., Kurata, H., Naganawa, A., Otsuki, K., Matsushita, T., Sekiguchi, T., Kakuuchi, A., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.031 · Cited by 22
Sphingosine-1-phosphate signaling in blood pressure regulation
Intapad, S. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00572.2018 · Cited by 22
He, Y., Shi, B., Zhao, X., & Sui, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7999 · Cited by 23
“Extracellular S1P was reported to act as a primary messenger, or ligand receptor, either inside or outside the cell via the activation of five specific G‐protein‐coupled receptors, denoted as S1P receptors 1-5 (S1PR1-5), located at the cell surface and characterized by the cell type‐specific expression pattern (6,14-2…”
Imeri, F., Tanturovska, B. S., Schwalm, S. A., Saha, S., Zeng-Brouwers, J., Pavenstädt, H., Pfeilschifter, J. M., Schaefer, L., & Huwiler, A. (2021) · Matrix Biology · doi:10.1016/j.matbio.2021.05.003 · Cited by 22
“Most of the actions of S1P are mediated by activation of cell surface S1P receptors, of which five subtypes have been identified, denoted as S1P1 5 [4,5].”
BackgroundChawla, S., Rahar, B., Tulswani, R., & Saxena, S. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172877 · Cited by 22
Gallop, D., Scanlon, K. M., Ardanuy, J., Sigalov, A. B., Carbonetti, N. H., & Skerry, C. (2021) · Infection and Immunity · doi:10.1128/iai.00126-21 · Cited by 20
McGowan, E. M., Lin, Y., & Chen, S. (2022) · Cancers · doi:10.3390/cancers14030535 · Cited by 22
Lee, C., Chen, Y., Hernandez, E., Pong, R.-C., Ma, S., Hofstad, M. E., Kapur, P., Zhau, H. E., Chung, L. W. K., Lai, C., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.695 · Cited by 21
Sphingosine‐1‐phosphate related signalling pathways manipulating virus replication
Zhang, L., Liu, J., Xiao, E., Han, Q., & Wang, L. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2415 · Cited by 22
“S1PR4 is more highly expressed in lymphoid tissue and lung tissue,(38) while S1PR5 is primarily expressed in the brain and skin.(31,39) Different sig-”
BackgroundThe role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury
Mihanfar, A., Nejabati, H. R., Fattahi, A., Latifi, Z., Pezeshkian, M., Afrasiabi, A., Safaie, N., Jodati, A., & Nouri, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27353 · Cited by 22
“Further, some downstream effectors of S1P receptors are identified, which include adenylate cyclase, phospholipase C, phosphatidylinositol‐3 kinase (PI3K), Ras, Rho, and intracellular calcium (Blaho & Hla, 2014; Chun, Hla, Lynch, Spiegel, & Moolenaar, 2010).”
Bone marrow sinusoidal endothelium as a facilitator/regulator of cell egress from the bone marrow
Hassanshahi, M., Hassanshahi, A., Khabbazi, S., Su, Y., & Xian, C. J. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.024 · Cited by 25
Tydén, H., Lood, C., Jönsen, A., Gullstrand, B., Kahn, R., Linge, P., Kumaraswamy, S. B., Dahlbäck, B., & Bengtsson, A. A. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1890-2 · Cited by 23
Chumanevich, A. P., Wedman, P., & Oskeritzian, C. A. (2016) · Mediators of Inflammation · doi:10.1155/2016/1503206 · Cited by 23
Pierucci, F., Frati, A., Battistini, C., Matteini, F., Iachini, M. C., Vestri, A., Penna, F., Costelli, P., & Meacci, E. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.040 · Cited by 23
Pors, S. E., Harðardóttir, L., Olesen, H. Ø., Riis, M. L., Jensen, L. B., Andersen, A. S., Cadenas, J., Grønning, A. P., Colmorn, L. B., Dueholm, M., et al. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa022 · Cited by 21
Zhang, Z., Li, W., Heng, Z., Zheng, J., Li, P., Yuan, X., Niu, W., Bai, C., & Liu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20491 · Cited by 20
“Some studies reaffirmed the conclusion that an antagonistic relationship existed between S1PR1 and S1PR2 in the vascular endothelium during tissue injury and disease [22].”
BackgroundBigi, A., Cascella, R., Fani, G., Bernacchioni, C., Cencetti, F., Bruni, P., Chiti, F., Donati, C., & Cecchi, C. (2022) · FEBS Journal · doi:10.1111/febs.16579 · Cited by 22
Wang, X., Li, M., Yu, Y., Liu, G., Yu, Y. Q., Zou, Y., Ge, J., & Chen, R. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28434 · Cited by 20
“2019;234:18029-18040. wileyonlinelibrary.com/journal/jcp © 2019 Wiley Periodicals, Inc. | 18029 Sphingosine 1‐phosphate receptors (S1PRs) belong to the G‐protein‐ coupled receptors family and widely locate on cellular membrane structures (Blaho & Hla, 2014).”
Backgroundvan den Brand, A. D., Bajard, L., Steffensen, I., Brantsæter, A. L., Dirven, H. A. A. M., Louisse, J., Peijnenburg, A., Ndaw, S., Mantovani, A., Santis, B. D., et al. (2022) · Toxins · doi:10.3390/toxins14040279 · Cited by 19
“It is further of interest to note that So-1-P is also able to activate So-1-P receptors, a class of G protein-coupled receptors [98], but whether this So-1-P receptor activation leads to HDAC inhibition has not yet been described.”
BackgroundKim, S., & Sieburth, D. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0536-18.2018 · Cited by 20
“S1P is known to be secreted from a number of cell types and S1P concentrations are high in the circulation (Blaho and Hla, 2014; Nagahashi et al., 2014).”
BackgroundTanturovska, B. S., Lange, A. I., Schwalm, S. A., Pfeilschifter, J. M., Coldewey, S. M., & Huwiler, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041240 · Cited by 22
“S1P primarily acts as an extracellular high-affinity ligand and an activator of the five G protein-coupled receptors named S1P1–5 [11].”
BackgroundReduction in serum sphingosine 1-phosphate concentration in malaria
Punsawad, C., & Viriyavejakul, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180631 · Cited by 19
Barrier maintenance by S1P during inflammation and sepsis
Ziegler, A. C., & Gräler, M. H. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1940069 · Cited by 22
Eosinophilic esophagitis: New molecules, better life?
Lam, A. Y., Ma, C., Lee, J. K., & Bredenoord, A. J. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102183 · Cited by 19
Arseni, L., Sharma, R., Mack, N. L., Nagalla, D., Ohl, S., Hielscher, T., Singhal, M., Pilz, R., Augustin, H. G., Sandhoff, R., et al. (2023) · Cancers · doi:10.3390/cancers15020479 · Cited by 19
“The heterodimerization of these receptors via different G-alpha subunits allows S1P to specifically exert its influence in numerous pathways to induce growth, differentiation, cell migration, and cell trafficking [7,8].”
BackgroundWang, S., Tian, Z., Lu, Y., Huang, Z., Fan, Y., Li, B., Zheng, H., Wu, X., Wang, M., Zhao, J., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80256 · Cited by 19
“S1PR1-3 are essentially widely distributed, whereas S1PR4 and S1PR5 are mainly exclusively expressed in specific cell types [15].”
BackgroundCohen, N. A., Choi, D., Garcia, N. M., Choi, N. K., Picker, E. A., Cleveland, N. K., Cohen, R. D., Dalal, S. R., Pekow, J. R., & Rubin, D. T. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08178-8 · Cited by 20
“S1P is a membrane-derived lysophospholipid signaling molecule that primarily functions through the activation of five cell-surface G protein-coupled receptors and regulates lymphocyte egress from the spleen and lymph nodes into the systemic circulation [5, 6].”
Sphingolipid paracrine signaling impairs keratinocyte adhesion to promote melanoma invasion
Noujarède, J., Carrié, L., Garcia, V., Grimont, M., Eberhardt, A., Mucher, E., Genais, M., Schreuder, A., Carpentier, S., Ségui, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113586 · Cited by 22
Yusuf, A. M., Zhang, X., Gulbins, E., Peng, Y., Hagemann, N., & Hermann, D. M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106682 · Cited by 23
“Release of exosomes can be reduced by inhibition of neutral sphingomyelinase (NSM)-mediated sphingomyelin hydrolysis using GW4869, spiroepoxide or glutathione (Trajkovic et al., 2008).”
MethodAtherogenic lipids and macrophage subsets
Getz, G. S., & Reardon, C. A. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000217 · Cited by 22
Role of Sphingosine 1-Phosphate Signalling Axis in Muscle Atrophy Induced by TNFα in C2C12 Myotubes
Bernacchioni, C., Ghini, V., Squecco, R., Idrizaj, E., Garella, R., Puliti, E., Cencetti, F., Bruni, P., & Donati, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031280 · Cited by 19
“The mechanism of action of S1P is dual since it can act as an intracellular messenger and as a ligand of five different specific G protein-coupled receptors (S1PR), named S1P1-5 [17].”
BackgroundDiscovery of novel S1P2 antagonists. Part 1: Discovery of 1,3-bis(aryloxy)benzene derivatives
Kusumi, K., Shinozaki, K., Kanaji, T., Kurata, H., Naganawa, A., Otsuki, K., Matsushita, T., Sekiguchi, T., Kakuuchi, A., & Seko, T. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.02.029 · Cited by 19
Sphingosine Kinases as Druggable Targets
Pyne, S., Adams, D. R., & Pyne, N. J. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_96 · Cited by 20
Meng, G., Wuest, M., Tang, X., Dufour, J. H., Zhao, Y., Curtis, J. M., McMullen, T. P. W., Murray, D. L., Wuest, F. R., & Brindley, D. N. (2019) · Cancers · doi:10.3390/cancers11111816 · Cited by 18
Das, K., Keshava, S., Mukherjee, T., Wang, J., Magisetty, J., Kolesnick, R., Pendurthi, U. R., & Rao, L. V. M. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.08.025 · Cited by 19
Oliveira‐Paula, G. H., Liu, S., Maira, A., Ressa, G., Ferreira, G. C., Quintar, A. A., Jayakumar, S., Almonte, V. M., Parikh, D., Valenta, T., et al. (2024) · Science Advances · doi:10.1126/sciadv.adg9278 · Cited by 25
“Generated by the phosphorylation of sphingosine by sphingosine kinases, S1P binds to five distinct G protein– coupled S1P receptors (S1PR1 to S1PR5) ( 5 ).”
BackgroundSelf-citationThe antithetic role of ceramide and sphingosine‐1‐phosphate in cardiac dysfunction
Cirillo, F., Piccoli, M., Ghiroldi, A., Monasky, M. M., Rota, P., Rocca, P. L., Tarantino, A., D’Imperio, S., Signorelli, P., Pappone, C., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30235 · Cited by 20
“…messenger, and extracellularly, as a ligand for five different high‐affinity G protein‐coupled receptors (GPCRs), originally known as the endothelial differentiation genes (EDG1‐5) but recently renamed S1P receptors (S1PR1‐5; Blaho & Hla, 2014; Morozov et al., 2013; Spiegel & Milstien, 2000).”
BackgroundEstrada, S. M., Thagard, A. S., Dehart, M. J., Damicis, J. R., Dornisch, E. M., Ippolito, D. L., Burd, I. D., Napolitano, P. G., & Ieronimakis, N. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2196-7 · Cited by 19
Kusumi, K., Shinozaki, K., Yamaura, Y., Hashimoto, A., Kurata, H., Naganawa, A., Ueda, H., Otsuki, K., Matsushita, T., Sekiguchi, T., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.022 · Cited by 18
Ordóñez, Y. F., González, J., Bedia, C., Casas, J., Abad, J. L., Delgado, A., & Fabriàs, G. (2016) · Molecular BioSystems · doi:10.1039/c5mb00852b · Cited by 18
High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms
White, C. R., Giordano, S. S., & Anantharamaiah, G. M. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2016.04.007 · Cited by 19
Mirzaian, M., Wisse, P., Ferraz, M. J., Marques, A. R. A., Gabriel, T. L., van Roomen, C. P. A. A., Ottenhoff, R., van Eijk, M., Codée, J. D. C., van der Marel, G. A., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.017 · Cited by 20
Vienken, H., Mabrouki, N., Grabau, K., Claas, R. F., Rudowski, A., Schömel, N., Pfeilschifter, J. M., Lütjohann, D., van Echten‐Deckert, G., & zu Heringdorf, D. M. (2017) · Scientific Reports · doi:10.1038/srep43575 · Cited by 19
Deciphering the role of sphingosine 1‐phosphate in central nervous system myelination and repair
Binish, F., & Xiao, J. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16228 · Cited by 22
Sands, B. E., Panaccione, R., D’Haens, G., Schreiber, S., Jairath, V., DuVall, A., Kierkuś, J., Walczak, M., Naik, S. U., Gilder, K. M., et al. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00386-8 · Cited by 18
Hou, X., Zhu, J., Chen, B., Watterson, S. H., Pitts, W. J., Dyckman, A. J., Carter, P. H., Mathur, A., & Zhang, H. (2016) · Organic Process Research & Development · doi:10.1021/acs.oprd.6b00112 · Cited by 17
Luo, Z., Han, J., Liu, H., Rosenberg, A. J., Chen, D. L., Gropler, R. J., Perlmutter, J. S., & Tu, Z. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02609b · Cited by 17
Zhang, J., Zhang, M., Yu, J., Shang, Y., Jiang, K., Jia, Y., Wang, J., & Yang, K. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.127900 · Cited by 18
Mücke, V. T., Schwarzkopf, K. M., Thomas, D., Mücke, M. M., Rüschenbaum, S., Trebicka, J., Pfeilschifter, J. M., Zeuzem, S., Lange, C. M., & Grammatikos, G. (2020) · Hepatology Communications · doi:10.1002/hep4.1561 · Cited by 17
“Extracellular S1P can bind to five different G protein-coupled receptors, named S1P1-5, activating different signaling pathways.(18) Modulation of extracellular S1P levels or activation/inactivation of S1P receptors has recently been of great interest in preclinical/clinical trials and is already established in medica…”
BackgroundInfluentialBernacchioni, C., Rossi, M., Vannuzzi, V., Prisinzano, M., Seidita, I., Raeispour, M., Muccilli, A., Castiglione, F., Bruni, P., Petraglia, F., et al. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.12.007 · Cited by 18
Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines
Bolli, M. H., Lescop, C., Birker, M., de Kanter, R., Hess, P., Kohl, C., Nayler, O., Rey, M., Sieber, P., Velker, J., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.020 · Cited by 17
“While the physiological effects of S1PeS1P receptor signalling have been studied in many organs and tissues [1] including the nervous system [12,13], the lung [14,15], the cardiovascular system [7,16e18] bone tissue [19], and haematopoietic and immune cells [20e23], the observation that lymphocytes exposed to a synthe…”
BackgroundKsiążek, M., Charmas, M., Klusiewicz, A., Zabielski, P., Długołęcka, B., Chabowski, A., & Baranowski, M. (2017) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12910 · Cited by 18
Highly Aggressive Multiple Sclerosis
Bowen, J. D. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000731 · Cited by 19
Bile acid modulation of host immunity
Anh, N. B., Yang, X., & Hang, H. C. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70014 · Cited by 17
Moritz, E., Jedlitschky, G., Negnal, J., Tzvetkov, M. V., Daum, G., Dörr, M., Felix, S. B., Völzke, H., Nauck, M. A., Schwedhelm, E., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s302117 · Cited by 18
The pleiotropic role of HDL in autoimmune diseases
Parra, S., Castro, A., & Masana, L. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.09.002 · Cited by 17
Emeterio, C. L. S., Hymel, L. A., Turner, T., Ogle, M. E., Pendleton, E. G., York, W. Y., Olingy, C. E., Liu, A. Y., Lim, H. S., Sulchek, T., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.650289 · Cited by 16
“Because systemically administered FTY720 is known to induce lymphopenia by suppression of lymphocyte egress from lymph nodes (Blaho and Hla, 2014), we sought to determine whether localized administration of the drug resulted in any system-level effects.”
BackgroundPetrusca, D. N., Lee, K. P., & Galson, D. L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.925807 · Cited by 16
“Extracellular S1P signals through binding to one of five G-protein-coupled receptors (S1PR1-S1PR5) thus participating in regulation of several cell processes such as cell survival, proliferation and migration (Figure 2A) (44).”
BackgroundSuilik, H. A., Jaber, F. S., Abuelazm, M. T., Ramadan, A., Elzeftawy, M. A., Elrosasy, A., Youssef, R. A., Abdelazeem, B., Hashash, J. G., Farraye, F. A., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01829-6 · Cited by 17
“Additionally, it contributes to the maintenance of barrier integrity through its expression on endothelial cells [9, 10, 18].”
Czubowicz, K., Cieślik, M., Pyszko, J., Strosznajder, J. B., & Strosznajder, R. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8807-5 · Cited by 17
“S1P synthesized in the cell by sphingosine kinases is released, via the ABC family of transporters from the cell and is able to act in an autocrine or paracrine manner [18, 19].”
BackgroundLemos, J. P., Smaniotto, S., Messias, C. V., Moreira, O. C., Cotta-de-Almeida, V., Dardenne, M., Savino, W., & Mendes‐da‐Cruz, D. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051446 · Cited by 16
“When binding to one of its five receptors (S1P1–5), S1P participates in various cellular processes, such as proliferation, adhesion, death and migration [12,13].”
BackgroundKim, M. S., Park, J., Lee, E. J., Kim, S., Shin, S., Ahn, J., Jung, Y., Park, I., & Park, W. (2018) · Oncology Reports · doi:10.3892/or.2018.6689 · Cited by 21
“Ceramide can be metabolized by cerami-dase to sphingosine, and sphingosine can be phosphorylated by one of two SphKs (39).”
Neßlauer, A.-M., Gläser, A., Gräler, M. H., Engelmann, R., Müller‐Hilke, B., Frank, M., Burstein, C., Rolfs, A., Neidhardt, J., Wree, A., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1088-2 · Cited by 17
Essis, S. A., Laurier-Laurin, M.-É., Pépin, É., Cyr, M., & Massicotte, G. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.055 · Cited by 17
Epigenetic Control of Alveolar Macrophages: Impact on Lung Health and Disease
Parajuli, N., Subedi, K., Solone, X. K., Jiang, A., Zhou, L., & Mi, Q. (2025) · Cells · doi:10.3390/cells14090640 · Cited by 16
“Among numerous genes, sphingosine-1-phosphate receptor 5 ( S1PR5 ) encodes a G protein-coupled receptor and binds the lipid-signaling molecule sphingosine 1-phosphate in AMs and is known for regulating lung function and efferocytosis process [125,126].”
Izquierdo, M. C., Shanmugarajah, N., Lee, S. X., Kraakman, M. J., Westerterp, M., Kitamoto, T., Harris, M., Cook, J. R., Gusarova, G. A., Zhong, K., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci146219 · Cited by 15
“S1P is a bioactive sphingolipid that signals through a series of GPCRs (S1P receptors 1–5) present on a variety of cell types (5, 6).”
BackgroundPositron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies
Raval, N. R., Wetherill, R. R., Wiers, C. E., Dubroff, J. G., & Hillmer, A. T. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.08.008 · Cited by 15
“promotes cellular survival and potently regulates immune responses in the brain.(228) Activation of S1PR1 induces an anti-inflammatory phenotype in the brain's immune system(229) while inhibiting S1PR1 attenuates proinflammatory chemokine release.”
BackgroundDhillon-LaBrooy, A., Braband, K. L., Tantawy, E., Rampoldi, F., Kao, Y.-S., Boukhallouk, F., Velásquez, L. N., Mamareli, P., Silva, L., Damasceno, L. E. A., et al. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.09.275 · Cited by 17
Does cardiovascular risk matter in IBD patients?
Tilg, H., Fuméry, M., & Hedin, C. R. H. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13735 · Cited by 17
“Migration of lymphocytes from the spleen and lymph nodes occurs along a concentration gradient of S1P and is attenuated in the absence of S1P1 receptors on the cell surface, reducing lymphocyte egress from spleen and lymph nodes [64].”
BackgroundRole of HDL-Associated Proteins and Lipids in the Regulation of Inflammation
White, R., Giordano, S. S., & Datta, G. (2017) · InTech eBooks · doi:10.5772/67141 · Cited by 20
“ApoM also plays an important role in the cytoprotective response to S1P by binding the sphingolipid and facilitating its incorporation into HDL particles [75, 79, 80].”
BackgroundKremer, L. D., Taleb, O., Boehm, N., Mensah‐Nyagan, A. G., Trifilieff, É., Seze, J. D., & Brun, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1441-4 · Cited by 15
Ma, W., Zhang, M., Liu, S., Wang, M., Shi, Y., Yang, T., Li, X., & Zhu, L. D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134599 · Cited by 15
Puhl, D. L., Funnell, J. L., D’Amato, A. R., Bao, J., Zagorevski, D. V., Pressman, Y., Morone, D., Haggerty, A. E., Oudega, M., & Gilbert, R. J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00937 · Cited by 15
“These receptors are ubiquitously expressed by cells in disparate physiological systems (Blaho and Hla, 2014).”
BackgroundDirect uptake of sphingosine-1-phosphate independent of phospholipid phosphatases
Goto, H., Miyamoto, M., & Kihara, A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100605 · Cited by 16
Kocovski, P., Tabassum-Sheikh, N., Marinis, S., Dang, P. T., Hale, M. W., & Orian, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639650 · Cited by 17
Koresawa, R., Yamazaki, K., Oka, D., Fujiwara, H., Nishimura, H., Akiyama, T., Hamasaki, S., Wada, H., Sugihara, T., & Sadahira, Y. (2016) · British Journal of Haematology · doi:10.1111/bjh.14054 · Cited by 17
“…sphingosine-1-phosphate receptor research paper First published online 8 April 2016 doi: 10.1111/bjh.14054 ª 2016 John Wiley & Sons Ltd British Journal of Haematology, 2016, 174, 264–274 (S1PR)1, S1PR2, S1PR3, S1PR4 and S1PR5 that are ubiquitously expressed in various tissues (Blaho & Hla, 2014).”
BackgroundInfluentialCeramide synthase 2 facilitates S1P‐dependent egress of thymocytes into the circulation in mice
Rieck, M., Kremser, C., Jobin, K., Mettke, E., Kurts, C., Gräler, M. H., Willecke, K., & Kolanus, W. (2017) · European Journal of Immunology · doi:10.1002/eji.201646623 · Cited by 15
Egom, E. E. A., Fitzgerald, R., Canning, R., Pharithi, R. B., Murphy, C. G., & Maher, V. M. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081800 · Cited by 15
Messias, C. V., Santana-Van-Vliet, E., Lemos, J. P., Moreira, O. C., Cotta-de-Almeida, V., Savino, W., & Mendes‐da‐Cruz, D. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148137 · Cited by 15
“Its major functions are related to vascular development and integrity, and to the mobility of different hematopoietic cells types (hematopoietic progenitors, T and B lymphocytes, natural killer T cells, dendritic cells, macrophages, neutrophils, mast cells and osteoclasts) [7, 16].”
BackgroundGanbaatar, B., Fukuda, D., Shinohara, M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., Hirata, K., & Sata, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.54916 · Cited by 16
S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation
Toyomoto, M., Inoue, A., Iida, K., Denawa, M., Kii, I., Kadji, F. M. N., Kishi, T., Im, D., Shimamura, T., Onogi, H., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.004 · Cited by 14
Rudzitis‐Auth, J., Christoffel, A., Menger, M. D., & Laschke, M. W. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15601 · Cited by 16
“The maintenance and formation of adherence junctions in the microvasculature is mediated by S1P-induced activation of S1P1 receptors (Blaho & Hla, 2014).”
BackgroundSphingosine 1-Phosphate Metabolism and Signaling
Hu, Y., & Dai, K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-0394-6_6 · Cited by 15
Mazzoli, A., Porzio, A. D., Gatto, C., Crescenzo, R., Nazzaro, M., Spagnuolo, M. S., Baccigalupi, L., Ricca, E., Amoresano, A., Fontanarosa, C., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109247 · Cited by 14
Seidita, I., Tusa, I., Prisinzano, M., Menconi, A., Cencetti, F., Vannuccini, S., Castiglione, F., Bruni, P., Petraglia, F., Bernacchioni, C., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202300323r · Cited by 15
Kumar, A., Baycin‐Hizal, D., Zhang, Y., Bowen, M. A., & Betenbaugh, M. J. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.09.006 · Cited by 16
Kinase-independent phosphoramidate S1P1 receptor agonist benzyl ether derivatives
James, E., Pertusati, F., Brancale, A., & McGuigan, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.011 · Cited by 15
Sphingosine‐1‐Phosphate Modulates the Effect of Estrogen in Human Osteoblasts
Tantikanlayaporn, D., Tourkova, I. L., Larrouture, Q. C., Luo, J., Piyachaturawat, P., Witt, M. R., Blair, H. C., & Robinson, L. J. (2018) · JBMR Plus · doi:10.1002/jbm4.10037 · Cited by 14
“That this overlap is due to functional biochemical linking is suggested by partial replication of the effects of S1P by the S1PR1 analog SEW2871 and that the S1P antagonist SKi opposed the effects of estradiol.”
BackgroundInfluentialMasuda‐Kuroki, K., Alimohammadi, S., & Nardo, A. D. (2023) · Cells · doi:10.3390/cells12192352 · Cited by 13
“Each of the five S1PRs is known to have a different effect on signaling pathways and cellular responses, and this response depends on the cell type in which the S1PRs are expressed [71].”
Unique pharmacological properties of etrasimod among S1P receptor modulators
Gaidarov, I., Komori, H. K., Stepniak, D. T., Lehmann‐Bruinsma, K., Dang, H., Chen, X., Anthony, T. L., Gatlin, J., Karimi-Naser, L. M., Ton, A., et al. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13907 · Cited by 15
“Among immune cells, S1P 5 expression is largely confined to NK cells, T cells, oligodendrocytes, and keratinocytes [5 – 8], and could potentially be involved in the trafficking of NK cells and their mobilization to inflamed organs [6,57,58], which may contribute to the therapeutic benefits seen across…”
InfluentialTavakol, S., Hoveizi, E., Tavakol, B., Azedi, F., Ebrahimi‐Barough, S., Keyhanvar, P., & Joghataei, M. T. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27774 · Cited by 13
“FTY‐720 as a drug in MS patients has receptors (S1PRs) on the surface of lymphocytes, neurons, microglia, astrocytes, and oligodendrocytes (Blaho & Hla, 2014) and has the potential to induce BDNF and influences neuronal cells.”
BackgroundKerage, D., Gombos, R. B., Wang, S., Brown, M. A., & Hemmings, D. G. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106874 · Cited by 13
Imaging S1P1 activation in vivo
Kono, M., & Proia, R. L. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.11.023 · Cited by 13
“Sphingosine-1-phosphate receptor 1 (S1P1) is the prototype for the sphingosine-1-phosphate (S1P) family of G protein-coupled receptors (GPCRs) (reviewed in [1]).”
Metadata
- Authors
- Blaho, V. A., & Hla, T.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Hla, Timothy
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 55
- Issue
- 8
- Pages
- 1596-1608
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4109755
- OpenAlex
- W2005467120
- Cited by
- 516
- References
- 184
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 35 · 2023: 49 · 2022: 31 · 2021: 59 · 2020: 48 · 2019: 46 · 2018: 52 · 2017: 49 · 2016: 48 · 2015: 29 · 2014: 10
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2239 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (R01HL067330, R37HL067330, R01HL089934, P01HL070694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, lysophospholipids, vascular barrier function, vascular tone, lymphocyte migration, chronic inflammation, autoimmunity, cancer, therapeutic target
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Lysophospholipids, Neoplasm Proteins, Neoplasms, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.